您当前的位置：
首页 >
文章列表页 >
Cost-utility analysis of enfortumab vedotin combined with pembrolizumab in the first-line treatment of advanced urothelial carcinoma
更新时间：2025-11-04

    • Cost-utility analysis of enfortumab vedotin combined with pembrolizumab in the first-line treatment of advanced urothelial carcinoma

    • “In the field of advanced urothelial carcinoma treatment, Chinese experts have constructed a dynamic Markov model to evaluate the economics of PemEV and GP regimens, providing decision-making basis for China's health system.”
    • ZHONGGUO YAOFANG   Vol. 36, Issue 20, Pages: 2548-2554(2025)

    • DOI：10.6039/j.issn.1001-0408.2025.20.11    

      CLC： R956;R979.1

    • Received：28 May 2025，

      Revised：2025-09-23，

      Accepted：25 September 2025，

      Published：30 October 2025

    移动端阅览

  • LU Qi,HUANG Jinyue,LING Xin,et al.Cost-utility analysis of enfortumab vedotin combined with pembrolizumab in the first-line treatment of advanced urothelial carcinoma[J].ZHONGGUO YAOFANG,2025,36(20):2548-2554. DOI： 10.6039/j.issn.1001-0408.2025.20.11.

  •  
  •  

0

Views

32

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Cost-utility analysis of benmelstobart plus anlotinib and chemotherapy as first-line treatment for extensive-stage small cell lung cancer
Pharmacoeconomic evaluation of serplulimab combined with chemotherapy regimens for the first-line treatment of extensive-stage small-cell lung cancer
Cost-utility analysis of sintilimab combined with chemotherapy in first-line treatment of advanced， recurrent or metastatic esophageal squamous cell carcinoma
Pharmacoeconomic evaluation of iruplinalkib therapy for advanced ALK-positive non-small cell lung cancer
Cost-utility analysis of switching to gemcitabine maintenance therapy for malignant mesothelioma patients after first-line chemotherapy

Related Author

GAO Ning
GAO Shengnan
ZHANG Yuxi
ZHANG Ranran
FENG Bing
LIU Guoqiang
NIE Xuyang
LIU Xuting

Related Institution

Hebei Provincial Association for Comprehensive Evaluation of Medicines and Health Technologies
Dept. of Clinical Pharmacy， Hebei Medical University Third Hospital
Dept. of Clinical Pharmacy， the Third Hospital of Hebei Medical University
Dept. of Clinical Pharmacology Research， the Fourth Hospital of Hebei Medical University
Dept. of Gastroenterology， the First Affiliated Hospital of Henan University of Chinese Medicine
0